While reporting financial results for the second quarter on Tuesday, animal health company Zoetis, Inc. (ZTS) raised its earnings, adjusted earnings and revenue guidance for the full year 2025.
For fiscal 2024, the company now projects earnings in a range of $5.90 to $6.0 per share and adjusted earnings in a range of $6.30 to $6.40 per share on revenues between $9.45 billion and $9.60 billion, with operational revenue growth of 6.5 to 8.0 percent.
Previously, the company expected earnings in a range of $5.85 to $5.95 per share and adjusted earnings in a range of $6.20 to $6.30 per share on revenues between $9.425 billion and $9.575 billion.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $6.21 per share on revenues of $9.50 billion for the year. Analysts' estimates typically exclude special items.
The company said the guidance reflects foreign exchange rates as of late July and the impact of enacted and assumptions on announced tariffs.
For the second quarter, the company reported net income attributable to Zoetis of $718 million or $1.61 per share, up from $624 million or $1.37 per share in the prior-year quarter.
Excluding items, adjusted earnings for the quarter were $1.76 per share, compared to $1.56 per share in the year-ago quarter.
Revenue for the quarter grew 4 percent to $2.46 billion from $2.36 billion in the same quarter last year. On an organic operational basis, revenue increased 8 percent, excluding the impact of foreign currency and divestitures.
The Street was looking for earnings of $1.61 per share on revenues of $2.41 billion for the quarter.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.